首页> 外文期刊>Urologia internationalis >Verapamil Inhibits the Pelvic Pressure Increase Corresponding to Flow Perfusion in the Porcine Percutaneous Renal Puncture Model
【24h】

Verapamil Inhibits the Pelvic Pressure Increase Corresponding to Flow Perfusion in the Porcine Percutaneous Renal Puncture Model

机译:维拉帕米抑制猪经皮肾穿刺模型中与血流灌注相对应的骨盆压力升高

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose: To estimate the effects of verapamil on pelvic pressure and investigate the possible systemic side effects in the porcine model during the procedure of increasing perfusion rates. Materials and Methods: In the experimental group, the pelvic pressure was recorded with increasing perfusion rates of the renal pelvis (0, 2, 4, 6, 8, 10, 14 and 20 ml/min) in response to intraluminal administration of increasing concentrations of verapamil (0, 0.1, 1, 10 and 100 mu g/ml) in isotonic saline. In the isotonic saline group, the pressure flow study was also done by increasing perfusion rates of the renal pelvis per animal using isotonic saline without verapamil. Results: Perfusion with 1,10 and 100 mu g/ml verapamil caused a decrease in pelvic pressure as a response to increasing flow rates, whereas perfusion with 0.1 mu g/ml verapamil did not obviously inhibit the increase of pelvic pressure at all perfusion rates compared with other concentrations. Importantly, the mean systolic blood pressure and mean heart rate were stable despite the increase of flow rates and verapamil concentrations. In the isotonic saline group, perfusion with isotonic saline resulted in an increase in the pelvic pressure with an increase in flow rates each time. Conclusions: Endoluminal administration of verapamil reduces pelvic pressure significantly without any untoward systemic cardiovascular side effects. (C) 2016 S. Karger AG, Basel
机译:目的:评估维拉帕米对盆腔压力的影响,并研究在提高灌注速率的过程中猪模型中可能的全身性副作用。材料和方法:在实验组中,随着腔内给药浓度的增加,记录的骨盆压伴随肾盂灌注速率的增加(0、2、4、6、8、10、14和20 ml / min)等渗盐水中的维拉帕米(0、0.1、1、10和100μg / ml)。在等渗盐水组中,还通过使用不含维拉帕米的等渗盐水提高每只动物的肾盂灌注率来进行压力流研究。结果:对1,10和100μg / ml维拉帕米的灌注会引起盆腔压力的降低,这是对流速增加的响应,而对0.1μg / ml维拉帕米的灌注并没有明显抑制所有灌注率下的骨盆压力的升高。与其他浓度相比。重要的是,尽管流速和维拉帕米浓度增加,平均收缩压和平均心率仍保持稳定。在等渗盐水组中,用等渗盐水灌注会导致骨盆压力升高,每次流量都增加。结论:腔内施用维拉帕米可显着降低骨盆压力,而没有任何不良的全身性心血管副作用。 (C)2016 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号